The empirical support for the radical cure strategy for eliminating Plasmodium vivax in China.

Guo-Jing Yang, Le-Yuan Shang, Xiao-Nong Zhou, Tamsin E Lee, Bo Bi, Michael White, Thomas A Smith, Melissa A Penny
Author Information
  1. Guo-Jing Yang: Key Laboratory of Tropical Translational Medicine of Ministry of Education, the First Affiliated Hospital, Hainan Medical University, Haikou, Hainan, 571199, People's Republic of China. guojingyang@hotmail.com. ORCID
  2. Le-Yuan Shang: Henan Center for Disease Control and Prevention, Zhengzhou, Henan, People's Republic of China.
  3. Xiao-Nong Zhou: National Health Commission Key Laboratory on Biology of Parasite and Vector, National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, People's Republic of China.
  4. Tamsin E Lee: Swiss Tropical and Public Health Institute, Socinstrasse, 57 4051, Basel, Switzerland.
  5. Bo Bi: Key Laboratory of Tropical Translational Medicine of Ministry of Education, the First Affiliated Hospital, Hainan Medical University, Haikou, Hainan, 571199, People's Republic of China.
  6. Michael White: Institut Pasteur, Université de Paris, G5 Épidémiologie et Analyse des Maladies Infectieuses, Département de Santé Globale, F-75015, Paris, France.
  7. Thomas A Smith: Swiss Tropical and Public Health Institute, Socinstrasse, 57 4051, Basel, Switzerland.
  8. Melissa A Penny: Swiss Tropical and Public Health Institute, Socinstrasse, 57 4051, Basel, Switzerland. melissa.penny@unibas.ch.

Abstract

BACKGROUND: With the recent certification by World Health Organization that the People's Republic of China is malaria-free, it is timely to consider how elimination of malaria was completed in People's Republic of China over the last 7 decades. Of the four widespread species of human malaria, Plasmodium vivax was the last to be eliminated by the national program of China. Understanding the incubation periods and relapses patterns of P. vivax through historical data from China is relevant for planning disease elimination in other malaria-endemic countries, with residual P. vivax malaria.
METHODS: We collated data from both published and unpublished malaria parasite inoculation experiments conducted between 1979 and 1988 with parasites from different regions of the People's Republic of China. The studies had at least two years of follow-up. We categorized P. vivax incubation patterns via cluster analysis and investigated relapse studies by adapting a published within-host relapse model for P. vivax temperate phenotypes. Each model was fitted using the expectation-maximization (EM) algorithm initialized by hierarchical model-based agglomerative clustering.
RESULTS: P. vivax parasites from the seven studies of five southern and central provinces in the People's Republic of China covering geographies ranging from the south temperate to north tropical zones. The parasites belonged to two distinct phenotypes: short- (10-19 days) or long-incubation (228-371 days). The larger the sporozoite inoculation, the more likely short incubation periods were observed, and with more subsequent relapses (Spearman's rank correlation between the number of inoculated sporozoites and the number of relapses of 0.51, p-value = 0.0043). The median of the posterior distribution for the duration of the first relapse interval after primary infection was 168.5 days (2.5% quantile: 89.7; 97.5% quantile: 227.69 days). The predicted survival proportions from the within-host model fit well to the original relapse data. The within-host model also captures the hypnozoite activation rates and relapse frequencies, which consequently influences the transmission possibility of P. vivax.
CONCLUSIONS: Through a within-host model, we demonstrate the importance of clearance of hypnozoites. A strategy of two rounds of radical hypnozoite clearance via mass drug administration (MDA) deployed during transmission (summer and autumn) and non-transmission (late spring) seasons had a pronounced effect on outbreaks during the malaria epidemics in China. This understanding can inform malaria control strategies in other endemic countries with similar settings.

Keywords

References

  1. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1990;8(1):22-5 [PMID: 2194692]
  2. Malar J. 2020 Nov 23;19(1):427 [PMID: 33228679]
  3. Am J Trop Med Hyg. 1986 Mar;35(2):263-74 [PMID: 3513645]
  4. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1988;6(3):166-8 [PMID: 3072114]
  5. R J. 2016 Aug;8(1):289-317 [PMID: 27818791]
  6. PLoS One. 2012;7(7):e39645 [PMID: 22808048]
  7. Am J Trop Med Hyg. 1953 Nov;2(6):958-69 [PMID: 13104804]
  8. Trends Parasitol. 2017 Apr;33(4):260-263 [PMID: 28077251]
  9. Nature. 1948 Jan 24;161(4082):126 [PMID: 18900752]
  10. Parasit Vectors. 2012 May 31;5:106 [PMID: 22650153]
  11. Malar J. 2013 Sep 16;12:324 [PMID: 24041296]
  12. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1989;7(1):28-31 [PMID: 2670311]
  13. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1988;6(2):107-10 [PMID: 3052905]
  14. Proc Biol Sci. 2016 Mar 30;283(1827):20160048 [PMID: 27030414]
  15. Am J Trop Med Hyg. 2001 Jan-Feb;64(1-2 Suppl):97-106 [PMID: 11425182]
  16. Lancet. 2019 Jul 27;394(10195):332-343 [PMID: 31229233]
  17. Chin Med J (Engl). 1996 Apr;109(4):266-71 [PMID: 8758285]
  18. Am J Trop Med Hyg. 1986 Nov;35(6):1077-99 [PMID: 3538919]
  19. Trans R Soc Trop Med Hyg. 1976;70(5-6):474-81 [PMID: 320726]
  20. Malar J. 2011 Oct 11;10:297 [PMID: 21989376]
  21. J Natl Malar Soc. 1950 Dec;9(4):381-96 [PMID: 14804098]
  22. Zhonghua Liu Xing Bing Xue Za Zhi. 1988 Dec;9(6):329-31 [PMID: 3073015]
  23. Bull World Health Organ. 1975;52(1):21-32 [PMID: 764993]
  24. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1989;7(3):181-3 [PMID: 2686859]
  25. Parassitologia. 2008 Dec;50(3-4):167-72 [PMID: 20055226]
  26. Bull World Health Organ. 1977;55(5):541-9 [PMID: 338188]
  27. Trans R Soc Trop Med Hyg. 2007 Apr;101(4):338-43 [PMID: 17204297]
  28. Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1986;4(2):101-5 [PMID: 3533306]
  29. Malar J. 2018 Aug 29;17(1):315 [PMID: 30157876]

MeSH Term

Animals
China
Disease Eradication
Humans
Malaria
Malaria, Vivax
Plasmodium vivax
Recurrence
Sporozoites

Word Cloud

Created with Highcharts 10.0.0ChinavivaxmalariaPRepublicrelapsemodelPeople'swithin-hostPlasmodiumincubationrelapsesdataparasitesstudiestwoeliminationlast7periodspatternscountriespublishedinoculationviatemperatenumber05%quantile:hypnozoitetransmissionclearancestrategyradicalBACKGROUND:recentcertificationWorldHealthOrganizationmalaria-freetimelyconsidercompleteddecadesfourwidespreadspecieshumaneliminatednationalprogramUnderstandinghistoricalrelevantplanningdiseasemalaria-endemicresidualMETHODS:collatedunpublishedparasiteexperimentsconducted19791988differentregionsleastyearsfollow-upcategorizedclusteranalysisinvestigatedadaptingphenotypesfittedusingexpectation-maximizationEMalgorithminitializedhierarchicalmodel-basedagglomerativeclusteringRESULTS:sevenfivesoutherncentralprovincescoveringgeographiesrangingsouthnorthtropicalzonesbelongeddistinctphenotypes:short-10-19 dayslong-incubation228-371 dayslargersporozoitelikelyshortobservedsubsequentSpearman'srankcorrelationinoculatedsporozoites51p-value=0043medianposteriordistributiondurationfirstintervalprimaryinfection1685 days2899722769 dayspredictedsurvivalproportionsfitwelloriginalalsocapturesactivationratesfrequenciesconsequentlyinfluencespossibilityCONCLUSIONS:demonstrateimportancehypnozoitesroundsmassdrugadministrationMDAdeployedsummerautumnnon-transmissionlatespringseasonspronouncedeffectoutbreaksepidemicsunderstandingcaninformcontrolstrategiesendemicsimilarsettingsempiricalsupportcureeliminatingEliminationModelPeople’sStrategy

Similar Articles

Cited By